Status:

COMPLETED

Influence of ABO Blood Group on the Risk of Complications in Alcoholic or Viral C Cirrhosis?

Lead Sponsor:

University Hospital, Caen

Collaborating Sponsors:

Thong DAO

Annie BOREL-DERLON

Conditions:

Alcoholic or Viral C Compensated Cirrhosis

Eligibility:

All Genders

18+ years

Brief Summary

The non-O blood group is a risk factor of deep vein thrombosis and recurrence of thromboembolic events, especially when associated with Factor 5 Leiden or prothrombin G20210A mutations. A recent study...

Eligibility Criteria

Inclusion

  • Patient with either alcoholic or viral C cirrhosis included in national cohorts CIRRAL and CIRVIR

Exclusion

  • Those of CIRRAL and CIRVIR with None Tumoral Portal Thrombosis prior history

Key Trial Info

Start Date :

January 1 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 22 2020

Estimated Enrollment :

1500 Patients enrolled

Trial Details

Trial ID

NCT03342170

Start Date

January 1 2019

End Date

January 22 2020

Last Update

January 27 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU de CAEN

Caen, France, 14033